Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks
Gilead Sciences and Merck presented Phase 2 results showing 94.2% viral suppression in HIV patients treated with islatravir and lenacapavir. Both weekly and daily treatments achieved comparable ...
24/7 Wall St8d
5 Blue Chip Dividend Stocks to Own If You Had to Hold Them Forever
These blue chip dividend stocks would be ideal for investors who had to hold them forever. They provide reliable streams of ...
Queerty12d
More good news about the twice-yearly PrEP injection
Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead has been testing it as an injectable form ...
Benzinga.com17d
Peeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights
Gilead Sciences GILD underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their ...
The Indian Express17d
Biopharma firm Gilead announces lenacapavir licensing for HIV treatment
International AIDS Society, an association of HIV/AIDS professionals, applauded moves by Gilead Sciences, a biopharma company, to make the generic injectable lenacapavir for HIV prevention widely ...
Reuters17d
Gilead to donate remdesivir for emergency use against Marburg disease in Rwanda
Oct 3 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda Medical Supply for emergency use in ...
AllAfrica.com18d
Rwanda: Marburg Virus - Gilead Confirms Remdesivir Drug Donation to Rwanda
American biopharmaceutical company Gilead Sciences, on Thursday, October 3, announced that it will donate about 5,000 vials of its antiviral drug Remdesivir for emergency use in response to the ...
The Financial Express18d
Dr. Reddy’s enters into licensing agreement with Gilead Sciences for HIV drug
(Image Credits: Pixabay) Dr. Reddy’s Laboratories Ltd. on Wednesday announced that it has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead Sciences Ireland UC ...
Business Line18d
Gilead inks pact with six generic drugmakers on long-acting HIV injectable, even as civil society oppose patent application
Six drugmakers have inked voluntary licensing (VL) agreements with Gilead Sciences to manufacture and distribute generic lenacapavir, a long-acting injectable HIV drug from the American drugmaker.
ProPakistani18d
Ferozsons Partners With Gilead Sciences to Produce HIV Medicine in Pakistan
Ferozsons Laboratories Limited (PSX: FEROZ) has entered into a non-exclusive voluntary license agreement with Gilead Sciences Ireland UC (Gilead Sciences) for the manufacture and sale of licensed ...
Armed robbery in Revesby18d
UNAIDS Reacts to Gilead's Lenacapavir Licensing Deal
Responding to today's announcement by Gilead on lenacapavir, UNAIDS Executive Director Winnie Byanyima said: "We welcome Gilead's announcement of licensing the break-through HIV medicine lenacapavir ...